Biblio

Export 1350 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Last Name is P  [Clear All Filters]
2020
P. Chatterjee, Mohammadi, M., Goozee, K., Shah, T. M., Sohrabi, H. R., Dias, C. B., Shen, K., Asih, P. R., Dave, P., Pedrini, S., Ashton, N. J., Hye, A., Taddei, K., Lovejoy, D. B., Zetterberg, H., Blennow, K., and Martins, R. N., “Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.”, J Alzheimers Dis, vol. 76, no. 1, pp. 291-301, 2020.
C. Liguori, Spanetta, M., Izzi, F., Franchini, F., Nuccetelli, M., Sancesario, G. Maria, Di Santo, S., Bernardini, S., Mercuri, N. Biagio, and Placidi, F., “Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.”, J Alzheimers Dis, vol. 74, no. 2, pp. 501-508, 2020.
B. - S. Rauchmann, Sadlon, A., and Perneczky, R., “Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1615-1626, 2020.
C. Domínguez-Vivero, Wu, L., Lee, S., Manoochehri, M., Cines, S., Brickman, A. M., Rizvi, B., Chesebro, A., Gazes, Y., Fallon, E., Lynch, T., Heidebrink, J. L., Paulson, H., Goldman, J. S., Huey, E., and Cosentino, S., “Structural Brain Changes in Pre-Clinical FTD MAPT Mutation Carriers.”, J Alzheimers Dis, vol. 75, no. 2, pp. 595-606, 2020.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
A. Kapoor, Bartha, R., Black, S. E., Borrie, M., Freedman, M., Gao, F., Herrmann, N., Mandzia, J., Ozzoude, M., Ramirez, J., Scott, C. J. M., Symons, S., Fischer, C. E., Frank, A., Seitz, D., Wolf, M. Uri, Verhoeff, N. Paul L. G., Naglie, G., Reichman, W., Masellis, M., Mitchell, S. B., Tang-Wai, D. F., Tartaglia, M. Carmela, Kumar, S., Pollock, B. G., Rajji, T. K., Finger, E., Pasternak, S. H., and Swartz, R. H., “Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Years.”, J Alzheimers Dis, vol. 74, no. 3, pp. 747-757, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
E. Tuzzi, Balla, D. Z., Loureiro, J. R. A., Neumann, M., Laske, C., Pohmann, R., Preische, O., Scheffler, K., and Hagberg, G. E., “Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.”, J Alzheimers Dis, vol. 73, no. 4, pp. 1481-1499, 2020.
F. Clay, Howett, D., Fitzgerald, J., Fletcher, P., Chan, D., and Price, A., “Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.”, J Alzheimers Dis, vol. 75, no. 1, pp. 23-43, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
S. Westwood, Baird, A. L., Anand, S. N., Nevado-Holgado, A. J., Kormilitzin, A., Shi, L., Hye, A., Ashton, N. J., Morgan, A. R., Bos, I., Vos, S. J. B., Baker, S., Buckley, N. J., Kate, M. Ten, Scheltens, P., Teunissen, C. E., Vandenberghe, R., Gabel, S., Meersmans, K., Engelborghs, S., De Roeck, E. E., Sleegers, K., Frisoni, G. B., Blin, O., Richardson, J. C., Bordet, R., Molinuevo, J. L., Rami, L., Wallin, A., Kettunen, P., Tsolaki, M., Verhey, F., Lleo, A., Sala, I., Popp, J., Peyratout, G., Martínez-Lage, P., Tainta, M., Johannsen, P., Freund-Levi, Y., Frölich, L., Dobricic, V., Legido-Quigley, C., Bertram, L., Barkhof, F., Zetterberg, H., B Morgan, P., Streffer, J., Visser, P. Jelle, and Lovestone, S., “Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.”, J Alzheimers Dis, vol. 74, no. 1, pp. 213-225, 2020.
2019
M. Khosravi, Peter, J., Wintering, N. A., Serruya, M., Shamchi, S. Pourhassan, Werner, T. J., Alavi, A., and Newberg, A. B., “18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.”, J Alzheimers Dis, vol. 70, no. 4, pp. 1197-1207, 2019.
K. E. Osborn, Alverio, J. M., Dumitrescu, L., Pechman, K. R., Gifford, K. A., Hohman, T. J., Blennow, K., Zetterberg, H., and Jefferson, A. L., “Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.”, J Alzheimers Dis, vol. 71, no. 1, pp. 281-290, 2019.
R. Peters, Ee, N., Peters, J., Booth, A., Mudway, I., and Anstey, K. J., “Air Pollution and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 70, no. s1, pp. S145-S163, 2019.
R. Peters, Ee, N., Peters, J., Booth, A., Mudway, I., and Anstey, K. J., “Air Pollution and Dementia: A Systematic Review.”, J Alzheimers Dis, vol. 70, no. s1, pp. S145-S163, 2019.
H. - B. Kim, Park, B., and Shim, J. - Y., “Anemia in Association with Cognitive Impairment: A Systematic Review and Meta-Analysis.”, J Alzheimers Dis, vol. 72, no. 3, pp. 803-814, 2019.
E. Werden, Khlif, M. Salah, Bird, L. J., Cumming, T., Bradshaw, J., Khan, W., Pase, M., Restrepo, C., Veldsman, M., Egorova, N., Patel, S. K., Gottlieb, E., and Brodtmann, A., “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
E. Werden, Khlif, M. Salah, Bird, L. J., Cumming, T., Bradshaw, J., Khan, W., Pase, M., Restrepo, C., Veldsman, M., Egorova, N., Patel, S. K., Gottlieb, E., and Brodtmann, A., “APOE ɛ4 Carriers Show Delayed Recovery of Verbal Memory and Smaller Entorhinal Volume in the First Year After Ischemic Stroke.”, J Alzheimers Dis, vol. 71, no. 1, pp. 245-259, 2019.
L. Letra, Matafome, P., Rodrigues, T., Duro, D., Lemos, R., Baldeiras, I., Patrício, M., Castelo-Branco, M., Caetano, G., Seiça, R., and Santana, I., “Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 67, no. 2, pp. 725-735, 2019.
M. Malek-Ahmadi, Chen, K., Perez, S. E., and Mufson, E. J., “Cerebral Amyloid Angiopathy and Neuritic Plaque Pathology Correlate with Cognitive Decline in Elderly Non-Demented Individuals.”, J Alzheimers Dis, vol. 67, no. 1, pp. 411-422, 2019.
A. Arighi, Di Cristofori, A., Fenoglio, C., Borsa, S., D'Anca, M., Fumagalli, G. Giulio, Locatelli, M., Carrabba, G., Pietroboni, A. Margherita, Ghezzi, L., Carandini, T., Colombi, A., Scarioni, M., De Riz, M. Alessandra, Serpente, M., Rampini, P. Maria, Scarpini, E., and Galimberti, D., “Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?”, J Alzheimers Dis, vol. 69, no. 3, pp. 663-669, 2019.
M. Haddad, Perrotte, M., Landri, S., Lepage, A., Fülöp, T., and Ramassamy, C., “Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 69, no. 3, pp. 751-762, 2019.
O. N. Groeneveld, Moneti, C., Heinen, R., de Bresser, J., Kuijf, H. J., Exalto, L. G., Boomsma, J. M. F., L Kappelle, J., Barkhof, F., Prins, N. D., Scheltens, P., van der Flier, W. M., and Biessels, G. Jan, “The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
J. Tanprasertsuk, Johnson, E. J., Johnson, M. Ann, Poon, L. W., Nelson, P. T., Davey, A., Martin, P., Barbey, A. K., Barger, K., Wang, X. - D., and Scott, T. M., “Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.”, J Alzheimers Dis, vol. 70, no. 1, pp. 35-49, 2019.
C. G. Schwarz, Gunter, J. L., Lowe, V. J., Weigand, S., Vemuri, P., Senjem, M. L., Petersen, R. C., Knopman, D. S., and Jack, C. R., “A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.”, J Alzheimers Dis, vol. 67, no. 1, pp. 181-195, 2019.

Pages